Andrey Semechkin

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ISCO

Current role

CEO, Board Member

2008-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	International Stem Cell CORP (ISCO)	—	$68,544	$20,000	—	—	—	—	$88,544
2024	International Stem Cell CORP (ISCO)	—	$66,480	—	—	—	—	—	$66,480
2023	International Stem Cell CORP (ISCO)	—	$66,560	—	—	$46,305	—	—	$112,865
2022	International Stem Cell CORP (ISCO)	—	$62,640	—	—	$333,503	—	—	$396,143
2021	International Stem Cell CORP (ISCO)	—	$58,096	—	—	$67,797	—	—	$125,893
2020	International Stem Cell CORP (ISCO)	—	$53,968	—	—	—	—	—	$53,968
2019	International Stem Cell CORP (ISCO)	—	$43,934	—	—	$157,274	—	—	$201,208
2018	International Stem Cell CORP (ISCO)	—	$48,212	—	—	$372,245	—	—	$420,457

No earnings-call appearances or filed executive changes recorded yet.